Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Quanterix Corp
(NQ:
QTRX
)
11.54
+0.10 (+0.87%)
Streaming Delayed Price
Updated: 10:23 AM EDT, Oct 9, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Quanterix Corp
< Previous
1
2
3
4
5
6
7
Next >
15 Stocks Moving in Tuesday's Pre-Market Session
October 12, 2021
Gainers Quanterix Corporation (NASDAQ: QTRX) shares rose 17.6% to $48.55 in pre-market trading after the company announced its Simoa phospho-Tau 181 blood test has been granted...
Via
Benzinga
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based pTau-181 Assay for Alzheimer’s Disease
October 11, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Hosts Webinar with Leading Pathologist from Emory Medical Laboratories
September 20, 2021
From
Quanterix Corporation
Via
Business Wire
Earnings Scheduled For May 5, 2021
May 05, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter. • EyePoint Pharmaceuticals (NASDAQ:EYPT...
Via
Benzinga
FDA Expands Quanterix's COVID-19 Antigen Test Emergency Use Label
September 14, 2021
The FDA has expanded the Emergency Use Authorization (EUA) label for Quanterix Corporation's (NASDAQ: QTRX) Simoa SARS-CoV-2 N Protein Antigen Test. The...
Via
Benzinga
Exposures
COVID-19
Product Safety
Quanterix Receives Label Expansion on Emergency Use Authorization for COVID Antigen Test
September 13, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix to Host Webinar with Leading Pathologist from Emory Medical Laboratories: “COVID-19 Testing in a Residential University Setting: Implementation, Insights, and Learnings”
September 10, 2021
From
Quanterix Corporation
Via
Business Wire
Return On Capital Employed Insights For Quanterix
September 03, 2021
Benzinga Pro data, Quanterix (NASDAQ:QTRX) reported Q2 sales of $25.37 million. Earnings fell to a loss of $13.67 million, resulting in a 39.63% decrease from last quarter. In Q1...
Via
Benzinga
Why Cassava Sciences Is Plunging Again Today
August 27, 2021
More red flags are emerging for this troubled Alzheimer's biotech company.
Via
The Motley Fool
Cassava Stock Dives Again As Lab Distances Itself From 'Data Manipulation' Allegations
August 27, 2021
The lab that tested samples for Cassava's Alzheimer's study distanced itself from the biotech Friday, and SAVA stock plunged again.
Via
Investor's Business Daily
Why Cassava Sciences Stock Investors Are Pulling Back
August 27, 2021
The neurodegenerative diseases-focused biopharma Cassava Sciences, Inc. (NASDAQ: SAVA) hasnow lost half of its market capitalization as skeletons continue to tumble out of...
Via
Benzinga
Quanterix Releases Statement
August 27, 2021
From
Quanterix Corporation
Via
Business Wire
63 Biggest Movers From Yesterday
August 27, 2021
Gainers Support.com, Inc. (NASDAQ: SPRT) shares surged 41.1% to settle at $19.70 on Thursday on abnormally high volume. TSR, Inc. (NASDAQ: TSRI) shares rose 28.1% to close at $11...
Via
Benzinga
45 Stocks Moving In Thursday's Mid-Day Session
August 26, 2021
Gainers Blue Water Acquisition Corp. (NASDAQ: BLUW) shares climbed 57% to $16.41. Blue Water Acquisition is expected to hold a special meeting of its stockholders on Friday,...
Via
Benzinga
Quanterix to Participate in the Canaccord Genuity 41st Annual Growth Conference
August 09, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Simoa® Technology Powers Breakthrough Alzheimer’s Disease Research Presented by Eli Lilly and Company at Alzheimer’s Association International Conference (AAIC) 2021
August 06, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation Releases Operating Results for Second Quarter of 2021
August 05, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release Second Quarter 2021 Financial Results on Aug. 5, 2021
July 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Michael Doyle as Chief Financial Officer
June 28, 2021
From
Quanterix Corporation
Via
Business Wire
Medical Device Maker Quanterix Stock Shows Rising Relative Strength
June 11, 2021
On Friday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating upgrading to 91 from 88 a day before.
Via
Investor's Business Daily
Quanterix’ Simoa Technology Powers Largest and Most Diverse Global Investigation of Plasma Neurofilament Light’s Role in Dementia Diagnosis
June 07, 2021
From
Quanterix Corporation
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For June 4, 2021
June 04, 2021
Upgrades According to Argus Research, the prior rating for Diageo PLC (NYSE:DEO) was changed from Hold to Buy. The current stock performance of Diageo shows a 52-week-high...
Via
Benzinga
Quanterix Chairman and CEO Kevin Hrusovsky to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference and Appear on the June 3 Episode of The Bio Report
June 02, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Masoud Toloue as President of Quanterix and Diagnostics
May 11, 2021
From
Quanterix Corporation
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
May 10, 2021
Gainers Protagenic Therapeutics (NASDAQ:PTIX) shares increased by 84.03% to $3.92 during Monday's regular session. Trading volume for this security as of 12:30 EST is...
Via
Benzinga
64 Biggest Movers From Yesterday
May 11, 2021
Gainers InnSuites Hospitality Trust (NYSE: IHT) shares jumped 82.6% to settle at $6.39 on Monday. Protagenic Therapeutics, Inc. (NASDAQ: PTIX) shares surged 53.5% to close at $3....
Via
Benzinga
Quanterix Corporation Releases Operating Results for First Quarter 2021
May 05, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Corporation to Release First Quarter 2021 Financial Results on May 5, 2021
April 28, 2021
From
Quanterix Corporation
Via
Business Wire
Quanterix Appoints Laurie Olson to Board of Directors
April 28, 2021
From
Quanterix Corporation
Via
Business Wire
Medical Device Maker Quanterix Sees Relative Strength Rating Rise To 86
April 27, 2021
On Tuesday, Quanterix stock hit an important technical milestone, with its Relative Strength (RS) Rating rising into to 86, up from 80 the day before.
Via
Investor's Business Daily
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.